CICOF(CICOF)
CICOF
No analyst ratings available
No analyst price targets available for CICOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $243.12B | $224.15B | $226.85B |
| Low | $228.69B | $208.62B | $212.27B |
| High | $262.65B | $244.82B | $246.39B |
| EBITDA Avg | $90.77B | $83.69B | $84.70B |
| Low | $85.39B | $77.89B | $79.26B |
| High | $98.07B | $91.41B | $92.00B |
| EBIT Avg | $72.40B | $66.75B | $67.56B |
| Low | $68.11B | $62.13B | $63.22B |
| High | $78.22B | $72.91B | $73.38B |
| Net Income Avg | $30.86B | $22.26B | $20.30B |
| Low | $28.28B | $20.40B | $18.61B |
| High | $34.32B | $24.75B | $22.58B |
| EPS Avg | $1.98 | $1.43 | $1.31 |
| Low | $1.82 | $1.31 | $1.20 |
| High | $2.21 | $1.59 | $1.45 |
| Analysts (Rev / EPS) | 9 / 1 | 9 / 1 | 3 / 1 |
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $55.10B |
| Low | $53.25B |
| High | $56.96B |
| EBITDA Avg | $20.57B |
| Low | $19.88B |
| High | $21.27B |
| EBIT Avg | $16.41B |
| Low | $15.86B |
| High | $16.96B |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 2 / — |